Atlas Trials

Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm

Clinical trial NCT01603459 · COMPLETED

Trial details

NCT number
NCT01603459
Sponsor
Merz Pharmaceuticals GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Spasticity of the Upper and Lower Limb Due to Cerebral Causes
Start date
2012-05-01
Primary completion
2014-09-01
Enrollment
155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.